OBD.L Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (25 Apr 2024 @ 11:35):

Oxford BioDynamics Plc, a biotechnology company, discovers and develops biomarkers for use in the pharmaceutical and biotechnology industry primarily in the United States and internationally...

Stats
Today's Volume	249 816
Average Volume	537 531
Market Cap	25.57M
EPS	£0 ( 2024-01-16 )
Next earnings date	( £0 ) 2024-05-28
Last Dividend	£0 ( N/A )
Next Dividend	£0 ( N/A )
P/E	-1.170
ATR14	£0.282 (3.34%)

Oxford Biodynamics PLC Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Oxford Biodynamics PLC Financials

Annual	2023
Revenue:	£510 000
Gross Profit:	£-6.83M (-1 338.43 %)
EPS:	£-0.0734

Q4	2023
Revenue:	£290 000
Gross Profit:	£-3.62M (-1 247.93 %)
EPS:	£-0.0415

Q2	2023
Revenue:	£220 000
Gross Profit:	£-3.21M (-1 457.73 %)
EPS:	£-0.0319

Q4	2022
Revenue:	£69 000.00
Gross Profit:	£-3.11M (-4 508.70 %)
EPS:	£-0.0367

Financial Reports:

No articles found.

Oxford Biodynamics PLC

Oxford BioDynamics Plc, a biotechnology company, discovers and develops biomarkers for use in the pharmaceutical and biotechnology industry primarily in the United States and internationally. The company provides EpiSwitch, a proprietary technology platform for the discovery, evaluation, validation, and monitoring of epigenetic biomarkers known as chromosome conformation signatures for use in medical testing kits, disease prediction, diagnosis, and treatment. Its products include EpiSwitch CiRT (Checkpoint Inhibitor Response Test), a validated prognostic test for predicting response to checkpoint inhibitor immunotherapy; EpiSwitch CST (Covid Severity Test), an advanced blood test for the prediction of COVID-19 severity in adults; and EpiSwitch Explorer Array Kit for high-resolution 3D genome profiling and biomarker discovery. Oxford BioDynamics Plc was incorporated in 2007 and is headquartered in Oxford, the United Kingdom.